首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1649503

認知診斷市場預測（2025-2030）

Cognitive Diagnostics Market - Forecasts from 2025 to 2030

出版日期: 2025年01月24日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

認知診斷市場預計將從 2025 年的 1,377.38 億美元成長到 2030 年的 1,950.61 億美元，預測期內的複合年成長率為 7.21%。

認知診斷市場涉及專注於認知障礙的評估和診斷的醫療技術。這個市場受到多種因素的推動，包括老年人口的成長、慢性病的流行以及人們對認知能力下降的認知的提高。研究表明，記憶力、執行功能、處理速度和推理等認知功能早在 30 多歲時就會開始下降。此外，研究表明，輕度認知障礙影響 10% 至 20% 的 65 歲以上成年人，並可能發展為更嚴重的認知問題。與認知功能相關的創新產品和新指標正在進一步推動市場成長。例如，Interaxon的Muse將於2024年9月推出名為Alpha Peak的新型認知功能指數。該指數是一系列領先的大腦健康工具的一部分，透過易於理解的評分系統為使用者提供個人化的見解，以提高他們的認知能力。使用者可以追蹤飲食、運動和睡眠等生活方式因素，並將這些因素與他們的 Alpha Peak 分數相關聯，以獲得最佳化他們習慣的客製化提示。

市場促進因素

老年人口增加：全球老年人口的增加是認知診斷和治療需求的主要驅動力。世界衛生組織（WHO）預測，到2030年，每六人中就有一人年齡在60歲或以上，總合約14億人。到2050年，這一數字預計將達到21億。老年失智症失智症疾病的流行（最常見的失智症）需要正確的診斷和治療，從而刺激了認知診斷市場的發展。

地理趨勢

認知診斷市場分為北美、南美、歐洲、中東和非洲以及亞太等地區。由於醫療保健行業的擴張、人口老化加劇以及對慢性病的日益關注，預計亞太地區將經歷顯著成長。亞洲開發銀行預計，到2050年，亞太地區四分之一的人口將超過60歲，60歲以上人口預計將比2010年增加兩倍，達到約13億。預計中國、日本、韓國和越南等國家將出現快速轉型。此外，對憂鬱症、失眠症和創傷後壓力症候群等疾病的研究不斷增加，預計將進一步推動對旨在改善該地區受影響人群生活品質的診斷工具的需求。

為什麼要購買這份報告？

深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2030 年的實際資料和預測
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭定位、策略與市場佔有率分析
收益成長和預測包括國家在內的細分市場和地區分析
公司概況（策略、產品、財務、主要發展等）

認知診斷市場區隔如下：

按診斷

腦部影像檢查
實驗室測試
精神狀態檢查
快速居家篩檢測試
神經心理學測試
腦電圖 (EEG)
認知功能和行為測試
神經精神調查問卷

按適應症

阿茲海默症
注意力不足過動症
失智症
癲癇相關認知障礙
輕度認知功能障礙
帕金森氏症相關認知障礙
中風相關認知障礙
創傷性腦損傷
其他

按最終用戶

醫院
神經科診所
認知行為療法中心
復健中心
學術和研究機構
診斷影像中心
其他

按地區

北美洲
美國
加拿大
墨西哥
南美洲
巴西
阿根廷
其他
歐洲
英國
德國
法國
義大利
西班牙
其他
中東和非洲
沙烏地阿拉伯
UAE
以色列
其他
亞太地區
中國
印度
日本
韓國
台灣
泰國
印尼
其他

世界概況
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 台灣
- 泰國
- 印尼
- 其他

第9章競爭格局及分析

主要企業和策略分析
新興企業和市場盈利
合併、收購、協議和合作
競爭儀錶板

第10章公司簡介

Cognivue, Inc.
Cambridge Cognition Ltd.
Diadem srl
C2N Diagnostics
Cogstate Ltd.
Viz.ai
Mind Maze
Neurocare Group AG
Anderson Diagnostics & Labs.
Altoida AG
BrainScope Company Inc.
Neurotrack Technologies Inc.
BrainCheck
Cyclops MedTech Pvt Ltd

簡介目錄

Product Code: KSI061617268

The cognitive diagnostics market is projected to grow at a CAGR of 7.21% over the forecast period, increasing from US$137.738 billion in 2025 to US$195.061 billion by 2030.

The cognitive diagnostics market pertains to medical technology focused on assessing and diagnosing cognitive disorders. This market is driven by several factors, including the increasing elderly population, the prevalence of chronic diseases, and heightened awareness of cognitive decline. Research indicates that cognitive functions such as memory, executive functions, processing speed, and reasoning may begin to deteriorate as early as a person's thirties. Additionally, studies show that mild cognitive impairment affects 10-20% of adults over 65, which can progress to more severe cognitive issues.Innovative products and new metrics related to cognitive functions are further propelling market growth. For instance, Muse by Interaxon launched a new cognitive performance metric called Alpha Peak in September 2024. This metric is part of a suite of advanced brain health tools that provide users with personalized insights to enhance cognitive performance through an easy-to-understand scoring system. Users can track lifestyle factors like diet, exercise, and sleep, correlating these with their Alpha Peak score and receiving tailored prompts for habit optimization.

Key Developments

Strategic Partnerships: In August 2024, Firefly Neuroscience, Inc. announced a strategic partnership with Neurology Consultants of Dallas (NCD) to enhance early detection and disease management for patients experiencing cognitive decline. NCD will integrate Firefly's Brain Network Analytics technology into its workflow and conduct clinical studies.
Investment in Innovative Testing: In March 2024, C2N Diagnostics, LLC received an investment of up to $15 million from Eisai Inc. This collaboration aims to scale access to their Precivity tests-innovative blood tests designed for patients with cognitive impairment that assist healthcare providers in diagnosing Alzheimer's disease pathology and informing treatment decisions.

Market Drivers

Growing Geriatric Population: The increasing elderly population globally is a primary driver for the demand for cognitive diagnostics and treatments. The World Health Organization (WHO) projects that by 2030, one in six individuals will be aged 60 or older, totaling approximately 1.4 billion people. By 2050, this number is expected to reach 2.1 billion. The prevalence of diseases like Alzheimer's- the most common form of dementia- necessitates proper diagnostics and treatments, thereby fueling the cognitive diagnostics market.

Geographical Trends

The cognitive diagnostics market is segmented into regions including North America, South America, Europe, the Middle East & Africa, and Asia Pacific. The Asia Pacific region is anticipated to experience significant growth due to its expanding healthcare industry, increasing elderly population, and rising concerns about chronic diseases. According to the Asian Development Bank, by 2050, one in four individuals in Asia and the Pacific will be over 60 years old, with the population aged over 60 expected to triple from 2010 levels to nearly 1.3 billion. Rapid transitions are anticipated in countries such as China, Japan, South Korea, and Vietnam. Additionally, growing research into conditions like depression, insomnia, and PTSD will further drive demand for diagnostic tools aimed at improving quality of life for affected individuals in this region.

Reasons for buying this report:-

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Cognitive diagnostics market has been segmented as following:

By Diagnosis

Brain Imaging Tests
Laboratory Testing
Mental Status Testing
Rapid Home Screening Tests
Neuropsychological Testing
Electroencephalogram (EEG)
Cognitive Function And Behavioral Tests
Neuropsychiatric Inventory Questionnaire

By Indication

Alzheimer's Disease
Attention Deficit / Hyperactivity Disorder
Dementia
Epilepsy-Related Cognitive Dysfunction
Mild Cognitive Impairment
Parkinson's Disease-Related Cognitive Dysfunction
Stroke-Related Cognitive Dysfunction
Traumatic Brain Injury
Others

By End User

Hospitals
Neurology Clinics
Cognitive Behavioral Therapy Centers
Rehabilitation Centers
Academic And Research Institutes
Diagnostic Imaging Centers
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Process
2.3. Data Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Supplier
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. COGNITIVE DIAGNOSTICS MARKET BY DIAGNOSIS

5.1. Introduction
5.2. Brain Imaging Tests
5.3. Laboratory Testing
5.4. Mental Status Testing
5.5. Rapid Home Screening Tests
5.6. Neuropsychological Testing
5.7. Electroencephalogram (EEG)
5.8. Cognitive Function And Behavioral Tests
5.9. Neuropsychiatric Inventory Questionnaire

6. COGNITIVE DIAGNOSTICS MARKET BY INDICATION

6.1. Introduction
6.2. Alzheimer's Disease
6.3. Attention Deficit / Hyperactivity Disorder
6.4. Dementia
6.5. Epilepsy-Related Cognitive Dysfunction
6.6. Mild Cognitive Impairment
6.7. Parkinson's Disease-Related Cognitive Dysfunction
6.8. Stroke-Related Cognitive Dysfunction
6.9. Traumatic Brain Injury
6.10. Others

7. COGNITIVE DIAGNOSTICS MARKET BY END USER

7.1. Introduction
7.2. Hospitals
7.3. Neurology Clinics
7.4. Cognitive Behavioral Therapy Centers
7.5. Rehabilitation Centers
7.6. Academic And Research Institutes
7.7. Diagnostic Imaging Centers
7.8. Others

8. COGNITIVE DIAGNOSTICS MARKET BY GEOGRAPHY

8.1. Global Overview
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia-Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Taiwan
- 8.6.6. Thailand
- 8.6.7. Indonesia
- 8.6.8. Others